{"id":"W1996305237","doi":"10.1016/j.jaci.2014.06.015","title":"The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency","year":2014,"lang":"en","type":"review","venue":"Journal of Allergy and Clinical Immunology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":149,"is_retracted":false,"has_abstract":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"UCB Pharma; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; Novartis Pharma; National Institutes of Health; British Heart Foundation; Deutsches Zentrum für Infektionsforschung; European Commission; Pfizer; GlaxoSmithKline; Deutsche Forschungsgemeinschaft; Concern Foundation; CSL Behring; Bundesministerium für Bildung und Forschung; Michael Smith Health Research BC; Conquer Cancer Foundation","keywords":"BCL10; Immunodeficiency; Biology; RAG2; Primary immunodeficiency; Recombination-activating gene; T-cell receptor; Genetics; Lymphoma; Immune system; Cancer research; Gene; Immunology; T cell","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003105949,0.0005060903,0.002872918,0.0002400306,0.0009872569,0.00005297458,0.001325376,0.001154793,0.000370787],"category_scores_gemma":[0.000530042,0.0002625532,0.001635457,0.0002114609,0.001973134,0.0001327256,0.0004428415,0.003139274,0.000155631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009839755,"about_ca_system_score_gemma":0.0003366877,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006548131,"about_ca_topic_score_gemma":0.00002893674,"domain_scores_codex":[0.9917758,0.003166362,0.004092609,0.0003726107,0.0001208367,0.0004718316],"domain_scores_gemma":[0.9903626,0.00396707,0.004384418,0.0007617491,0.0004888645,0.00003534339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009418757,0.0007101934,0.00001689206,0.0007961964,0.01962745,0.00001374508,0.0005115328,0.000001568933,0.005833046,0.004937219,0.01158954,0.9550207],"study_design_scores_gemma":[0.001032554,0.002248317,0.0003859526,0.001683153,0.000904949,0.0006118963,0.0003271106,5.970001e-7,0.00004047122,0.0001739731,0.9923306,0.0002604464],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001247594,0.9889512,0.0000574128,0.0003652088,0.00756198,0.0002829784,0.000002304401,0.00001588564,0.001515422],"genre_scores_gemma":[0.001980885,0.9942686,0.00001481157,0.0002309748,0.0002625764,0.00001019964,0.00005629107,0.00004189986,0.00313379],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.980741,"threshold_uncertainty_score":0.9999827,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05033133122761082,"score_gpt":0.3500078594279197,"score_spread":0.2996765282003089,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}